论文部分内容阅读
目的观察将雷贝拉唑联合左氧氟沙星及呋喃唑酮治疗慢性萎缩性胃炎患者的效果。方法抽取我院于2016年2月~2017年1月诊断为慢性萎缩性胃炎的58例患者作为实验对象。分为试验组以及对照组。试验组治疗时给予雷贝拉唑联合左氧氟沙星及呋喃唑酮,对照组给予雷尼替丁联合左氧氟沙星及呋喃唑酮。比较两组的治疗结果。结果试验组的总有效率与对照组相比更占优势,P<0.05;试验组的不良反应率较对照组显著降低,P<0.05,差异有统计学意义。结论与常规的治疗方法相比,对慢性萎缩性胃炎患者实施雷贝拉唑联合左氧氟沙星及呋喃唑酮的治疗方法,其临床效果很好,可在临床上推广。
Objective To observe the effect of rabeprazole combined with levofloxacin and furazolidone in patients with chronic atrophic gastritis. Methods Fifty-eight patients diagnosed as chronic atrophic gastritis in our hospital from February 2016 to January 2017 were selected as experimental subjects. Divided into experimental group and control group. Rabeprazole combined with levofloxacin and furazolidone were given to the experimental group while ranitidine combined with levofloxacin and furazolidone. The results of the two groups were compared. Results The total effective rate of the experimental group was more predominant than that of the control group (P <0.05). The adverse reaction rate of the experimental group was significantly lower than that of the control group (P <0.05). The difference was statistically significant. Conclusion Compared with the conventional treatment, the treatment of chronic atrophic gastritis rabeprazole combined with levofloxacin and furazolidone treatment, the clinical effect is good, can be clinically promoted.